SD BioSensor, Inc (137310.KS)
KRW 10740.0
(-4.62%)
KRW 10740.0
(-4.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 655.67 Billion | 2932 Billion | 2929.96 Billion | 1686.16 Billion | 72.96 Billion | 65.63 Billion |
| Cost of Revenue | 626.46 Billion | 1539 Billion | 1359.93 Billion | 828 Billion | 52.15 Billion | 45.59 Billion |
| Gross Profit | 29.2 Billion | 1392.99 Billion | 1570.03 Billion | 858.16 Billion | 20.81 Billion | 20.03 Billion |
| Operating Expenses | 374.08 Billion | 246.37 Billion | 205.99 Billion | 119.89 Billion | 19.29 Billion | 16.99 Billion |
| Selling, General and Administrative Expenses | 206.36 Billion | 88.29 Billion | 128.69 Billion | 81.92 Billion | 6.17 Billion | 12.45 Billion |
| Research and Development Expenses | 64.2 Billion | 45.76 Billion | 18.88 Billion | 10.38 Billion | 4.86 Billion | 4.26 Billion |
| Other Expenses | - | 112.31 Billion | 58.41 Billion | 27.58 Billion | 8.24 Billion | -275.54 Million |
| Cost and Expenses | 903.76 Billion | 1785.37 Billion | 1565.92 Billion | 947.89 Billion | 71.44 Billion | 62.59 Billion |
| Operating Income | -248.08 Billion | 1146.62 Billion | 1364.04 Billion | 738.26 Billion | 1.51 Billion | 3.03 Billion |
| Interest Expense | 49.22 Billion | 994.05 Million | 488.65 Million | 433.62 Million | 251.48 Million | 235.38 Million |
| Income Tax Expense | 29.29 Billion | 333.29 Billion | 376.38 Billion | 95.62 Billion | -928.64 Million | -142.1 Million |
| Earnings before Tax | -438.61 Billion | 1242.08 Billion | 1440.81 Billion | 717.23 Billion | 2.2 Billion | 3.82 Billion |
| Net Income | -467.71 Billion | 911.36 Billion | 1088.47 Billion | 615.63 Billion | 3.15 Billion | 3.03 Billion |
| Earnings Per Share Basic | -4218.95 | 8996.76 | 11.16 Thousand | 5990.92 | 30.68 | 29.50 |
| Earnings Per Share Diluted | -4218.95 | 8996.76 | 11.16 Thousand | 5990.92 | 30.68 | 29.50 |
| Weighted Average Shares Outstanding | 110.85 Million | 101.29 Million | 97.52 Million | 102.76 Million | 102.76 Million | 102.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 110.85 Million | 101.29 Million | 97.52 Million | 102.76 Million | 102.76 Million | 102.76 Million |
| Gross Margin | 0.04 | 0.48 | 0.54 | 0.51 | 0.29 | 0.31 |
| EBIT Margin | -0.38 | 0.44 | 0.50 | 0.43 | 0.08 | 0.11 |
| Profit Margin | -0.71 | 0.31 | 0.37 | 0.37 | 0.04 | 0.05 |
| EBITDA | -250.85 Billion | 1187.44 Billion | 1406.84 Billion | 746.23 Billion | 5.85 Billion | 8.46 Billion |
| Earnings Before Tax Margin | -0.38 | 0.39 | 0.47 | 0.44 | 0.02 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 167.46 Billion | 176.38 Billion | 655.67 Billion | 159.61 Billion | 151.02 Billion | 162.63 Billion |
| Cost of Revenue | 111.98 Billion | 112.46 Billion | 626.46 Billion | 118.04 Billion | 112.26 Billion | 126.93 Billion |
| Gross Profit | 55.47 Billion | 63.92 Billion | 29.2 Billion | 41.56 Billion | 38.76 Billion | 35.69 Billion |
| Operating Expenses | 70.35 Billion | 74.49 Billion | 277.29 Billion | 71.18 Billion | -83 Billion | -112.1 Billion |
| Selling, General and Administrative Expenses | 47.29 Billion | 54.84 Billion | - | 57.85 Billion | 83 Billion | 112.1 Billion |
| Research and Development Expenses | 22.52 Billion | 19.1 Billion | - | 14.05 Billion | 17.21 Billion | 16.67 Billion |
| Other Expenses | -543.82 Million | -539.31 Million | -10.86 Billion | 728.32 Million | -166 Billion | -224.2 Billion |
| Cost and Expenses | 182.34 Billion | 186.95 Billion | 903.76 Billion | 189.22 Billion | 112.26 Billion | 126.93 Billion |
| Operating Income | -14.88 Billion | -10.56 Billion | -248.08 Billion | -29.61 Billion | -44.23 Billion | -76.4 Billion |
| Interest Expense | 16.41 Billion | 16.43 Billion | 49.22 Billion | 14.71 Billion | 10.99 Billion | 14.5 Billion |
| Income Tax Expense | -5.7 Billion | -2.86 Billion | 29.29 Billion | -43.26 Billion | -1.16 Billion | 402.89 Million |
| Earnings before Tax | -22.5 Billion | -13.07 Billion | -437.62 Billion | -142.09 Billion | -64.97 Billion | -82.65 Billion |
| Net Income | -18.7 Billion | -11.14 Billion | -467.71 Billion | -98.42 Billion | -64.11 Billion | -82.48 Billion |
| Earnings Per Share Basic | -152.93 | -91.14 | - | -804.48 | -551.57 | -806.25 |
| Earnings Per Share Diluted | -152.93 | -91.14 | - | -804.48 | -551.57 | -806.25 |
| Weighted Average Shares Outstanding | 122.33 Million | 122.33 Million | 110.85 Million | 122.34 Million | 116.24 Million | 102.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.33 Million | 122.33 Million | 110.85 Million | 122.34 Million | 116.24 Million | 102.3 Million |
| Gross Margin | 0.33 | 0.36 | 0.04 | 0.26 | 0.26 | 0.22 |
| EBIT Margin | 0.12 | 0.14 | - | 0.08 | 0.26 | 0.22 |
| Profit Margin | -0.11 | -0.06 | -0.71 | -0.62 | -0.42 | -0.51 |
| EBITDA | 20.31 Billion | 24.65 Billion | - | 13.29 Billion | 38.76 Billion | 35.69 Billion |
| Earnings Before Tax Margin | -0.09 | -0.06 | -0.38 | -0.19 | -0.29 | -0.47 |
LIKHITHA
ENMPF
GCLT
4175
AMEGF
2376